Related Experiment Video
Updated: Aug 18, 2025

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
Published on: July 11, 2025
Nationwide Implementation of a Population Management Dashboard for Monitoring Direct Oral Anticoagulants: Insights
Michael P Dorsch1,2,3, Charity S Chen4, Arthur L Allen5
1College of Pharmacy (M.P.D.), University of Michigan, Ann Arbor.
Insights
A new dashboard improved direct oral anticoagulant prescribing in the Veterans Health Administration. The tool supported pharmacists in managing anticoagulation, showing rapid and sustained implementation across 94.7% of sites.
Area of Science:
- Pharmacology
- Health Informatics
- Public Health
Background:
- Direct oral anticoagulants (DOACs) are primary treatments for atrial fibrillation and venous thromboembolism.
- Evidence-based prescribing of DOACs is complex due to varied dosing, renal function considerations, and drug interactions.
- The Veterans Health Administration (VA) developed a population management dashboard to aid pharmacists in reviewing anticoagulant prescriptions.
Purpose of the Study:
- To evaluate the nationwide implementation and adoption of a population health dashboard designed to support evidence-based prescribing of direct oral anticoagulants.
- To assess the dashboard's reach, effectiveness, adoption, implementation, and maintenance within the Veterans Health Administration system.
Main Methods:
- The study utilized login data from the population management dashboard to assess its implementation.
- The Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework guided the evaluation.
- Data were collected between August 2016 and June 2020, covering 150 out of 164 VA sites.
Main Results:
- The dashboard was adopted by 150/164 (91.5%) VA sites, with 142/150 (94.7%) achieving moderate to high adoption by June 2020.
- Average unique users per site increased from 2.4 to 7.5 during the study period.
- Sustained adoption (> 6 months) was achieved in 126/150 (84.0%) of sites.
Conclusions:
- The population health dashboard was rapidly and successfully implemented and adopted nationwide within the VA system.
- The tool effectively supported evidence-based anticoagulant prescribing.
- Further research is needed to determine the clinical impact and to develop strategies for replicating this model in other healthcare systems.
Background:
Direct oral anticoagulants are first-line therapy for common thrombotic conditions, including atrial fibrillation and venous thromboembolism. Despite their strong efficacy and safety profile, evidence-based prescribing can be challenging given differences in dosing based on indication, renal function, and drug-drug interactions. The Veterans Health Affairs developed and implemented a population management dashboard to support pharmacist review of anticoagulant prescribing. The dashboard includes information about direct oral anticoagulants and dose prescribed, renal function, age, and weight, potential interacting medications, and the need for direct oral anticoagulant medication refills. It is a stand-alone system.
Methods:
Using login data from the dashboard, nationwide implementation was evaluated using elements from the Reach, Effectiveness, Adoption, Implementation, and Maintenance framework.
Results:
Between August 2016 and June 2020, 150/164 sites within the Veterans Health Affairs system used the dashboard, averaging 1875 patients per site. The dashboard was made available to sites on a staggered basis. Moderate or high adoption, defined as at least one login on at least 2 separate days per month, began slowly with 3/5 sites in the pilot phase but rapidly grew to 142/150 (94.7%) sites by June 2020. The average number of unique users per site increased from 2.4 to 7.5 over the study period. Moderate to high adoption of the dashboard's use was maintained for > 6 months in 126/150 (84.0%) sites by the end of the study period.
Conclusions:
There was rapid and sustained implementation and adoption of a population health dashboard for evidence-based anticoagulant prescribing across the national United States Veterans Health Administration health system. The impact of this tool on clinical outcomes and strategies to replicate this care model in other health systems will be important for broad dissemination and uptake.
More Related Videos
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Integrated Healthcare System
Anticoagulant Drugs: Low-Molecular-Weight Heparins

